HSCI and Stock Connect - Biotech Stocks Now Eligible; Inclusion & Exclusion Possibilities
Hang Seng Indexes Company (HSIL) reviews the constituents of the Hang Seng Composite Index (HSCI) on a half yearly basis in March and September...
745 Views
ECM Weekly (12 Apr 2020) - Akesobio, Auckland Intl Airport, Oil Search, Flight Centre and More
Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. Our focus...
335 Views
CanSino Biologics Placement: Liquidity Permits a Trade but Beware of COVID-19 Hype
CanSino Biologics' shareholder Lilly Asia Venture is selling USD 76 million worth of stake in CanSino Biologics. In this insight, we will take a...
376 Views
Ascletis Pharma: Sell the Hype Of (Possible) Coronavirus Clinical Trial
Ascletis Pharma has been the beneficiary of the Coronavirus as media reports mention that its drug candidates that aim to treat type 1 HIV is being...
446 Views
2019 Hong Kong IPO Analytics: How Did Insti and Retail Coverage Impact Deal Performance
Since the inception of our IPO research in 2015, the Aequitas Research team has covered over 452 IPOs, which raised over US$100m each, across the...
512 Views